Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Computational Study of Potential Galectin-3 Inhibitors in the Treatment of COVID-19
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 9, Pages 1208
Publisher
MDPI AG
Online
2021-09-14
DOI
10.3390/biomedicines9091208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane
- (2021) Yeol Kyo Choi et al. Journal of Chemical Theory and Computation
- Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
- (2021) Naveenchandra Suryadevara et al. CELL
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
- (2021) Matthew McCallum et al. CELL
- More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells
- (2021) Sonia Di Gaetano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exploring the Regulatory Function of the N ‐terminal Domain of SARS‐CoV‐2 Spike Protein through Molecular Dynamics Simulation
- (2021) Yao Li et al. Advanced Theory and Simulations
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development
- (2020) Christophe Dussouy et al. Chemical Biology & Drug Design
- Translational pharmacology of TD139, an inhaled small molecule galectin‐3 (Gal‐3) inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF)
- (2020) R. J. Slack et al. FASEB JOURNAL
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
- (2020) Carlo Perricone et al. JOURNAL OF AUTOIMMUNITY
- Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane
- (2020) Hyeonuk Woo et al. JOURNAL OF PHYSICAL CHEMISTRY B
- A potential role for Galectin-3 inhibitors in the treatment of COVID-19
- (2020) John L. Caniglia et al. PeerJ
- A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment
- (2020) Luciano Pirone et al. Frontiers in Molecular Biosciences
- Structural Characterization of N‐Linked Glycans in the Receptor Binding Domain of the SARS‐CoV‐2 Spike Protein and their Interactions with Human Lectins
- (2020) Maria Pia Lenza et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
- (2020) Jacques Fantini et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
- (2020) Sandhya Bangaru et al. SCIENCE
- Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein
- (2020) Nouredine Behloul et al. VIRUS RESEARCH
- The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV
- (2020) Mayanka Awasthi et al. Viruses-Basel
- Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
- (2020) Juan Garcia-Revilla et al. Frontiers in Immunology
- The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device
- (2020) Alexander N. Baker et al. ACS Central Science
- Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain
- (2020) Adriana Carino et al. Frontiers in Chemistry
- Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit
- (2020) Yanxing Cai et al. VIROLOGICA SINICA
- Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis
- (2020) Nikhil Hirani et al. EUROPEAN RESPIRATORY JOURNAL
- Interplay between Conformational Entropy and Solvation Entropy in Protein–Ligand Binding
- (2019) Maria Luisa Verteramo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension
- (2019) Syed Attique et al. International Journal of Environmental Research and Public Health
- Structure and Energetics of Ligand–Fluorine Interactions with Galectin‐3 Backbone and Side‐Chain Amides: Insight into Solvation Effects and Multipolar Interactions
- (2019) Rohit Kumar et al. ChemMedChem
- Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
- (2019) Young-Jun Park et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-π, and Halogen Bond Interactions
- (2018) Fredrik R. Zetterberg et al. ChemMedChem
- Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
- (2018) Salvatore Sciacchitano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elucidation of Hydrogen Bonding Patterns in Ligand-Free, Lactose- and Glycerol-Bound Galectin-3C by Neutron Crystallography to Guide Drug Design
- (2018) Francesco Manzoni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity
- (2018) Kristoffer Peterson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Recognition of a Thomsen-Friedenreich Antigen Mimetic Targeting Human Galectin-3
- (2018) Sabrina Santarsia et al. ChemMedChem
- Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
- (2017) David Lagorce et al. Scientific Reports
- Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition
- (2016) Tamara Delaine et al. CHEMBIOCHEM
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors
- (2016) Tung-Ju Hsieh et al. Scientific Reports
- A Computational Approach to Evaluate the Androgenic Affinity of Iprodione, Procymidone, Vinclozolin and Their Metabolites
- (2014) Corrado Lodovico Galli et al. PLoS One
- PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
- (2013) Daniel R. Roe et al. Journal of Chemical Theory and Computation
- Crystal Structure of Bovine Coronavirus Spike Protein Lectin Domain
- (2012) Guiqing Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Taloside Inhibitors of Galectin-1 and Galectin-3
- (2011) Patrick M. Collins et al. Chemical Biology & Drug Design
- CHARMM-GUI: A web-based graphical user interface for CHARMM
- (2008) Sunhwan Jo et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells
- (2008) Tamara Delaine et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now